Journal article
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
S Zoungas, M Woodward, Q Li, ME Cooper, P Hamet, S Harrap, S Heller, M Marre, A Patel, N Poulter, B Williams, J Chalmers
Diabetologia | Published : 2014
Abstract
© 2014 Springer-Verlag Berlin HeidelbergAims/hypothesis: Data are inconsistent regarding the associations between age, age at diagnosis of diabetes, diabetes duration and subsequent vascular complications.Methods: The associations between age (or age at diagnosis), diabetes duration and major macrovascular events, all-cause death and major microvascular events were examined in 11,140 patients with type 2 diabetes randomly allocated to intensive or standard glucose control in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Rates were calculated by 5 year baseline age (or age at diagnosis) and diabetes duration strata...
View full abstractGrants
Awarded by Servier
Funding Acknowledgements
ADVANCE was funded by grants from Servier and the National Health and Medical Research Council (NHMRC) of Australia (project grant ID 211086 and programme grant IDs 358395 and 571281). The sponsors had no role in data collection, data interpretation or the writing of the manuscript.